Endonovo Therapeutics (OTCMKTS:ENDV) Shares Pass Above 50-Day Moving Average – What’s Next?
by Doug Wharley · The Cerbat GemEndonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Endonovo Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Endonovo Therapeutics Stock Performance
About Endonovo Therapeutics
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Further Reading
- Five stocks we like better than Endonovo Therapeutics
- Dividend Payout Ratio Calculator
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- What is the S&P/TSX Index?
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI